# Baron Opportunity Fund Retail Shs (BIOPX): Mutual Fund Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/biopx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: Baron · Asset class: Equity - Strategy: Actively Managed · Inception: 2000-02-29 This fund predominantly directs its investments into common shares of American companies characterized by rapid growth, encompassing businesses of all market sizes. The primary criterion for selection is the potential for significant increases in stock value. While the fund manager has the flexibility to explore opportunities across diverse sectors and industries, the strategy particularly emphasizes enterprises expected to capitalize on groundbreaking technological innovations and developments. ## Key Facts | Metric | Value | |---|---| | Price | $61.04 | | Expense Ratio | 1.31% | | AUM (All Share Classes) | $2.14B | | NAV | $61.04 | | Holdings Count | — | | Distribution Yield (TTM) | 3.75% | | Annual Distribution (TTM) | $2.29 /share | | Distribution Frequency | Annual | | 52-Week Range | $47.46 – $66.29 | | Beta | 1.27 | ## Latest Distribution - Amount: $2.2870 /share - Ex-date: 2025-12-16 - Pay date: 2025-12-17 ## Frequently Asked Questions ### What does BIOPX invest in? This fund predominantly directs its investments into common shares of American companies characterized by rapid growth, encompassing businesses of all market sizes. The primary criterion for selection is the potential for significant increases in stock value. While the fund manager has the flexibility to explore opportunities across diverse sectors and industries, the strategy particularly emphasizes enterprises expected to capitalize on groundbreaking technological innovations and developments. ### What is the expense ratio of BIOPX? Baron Opportunity Fund Retail Shs (BIOPX) charges an expense ratio of 1.31%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is BIOPX? Baron Opportunity Fund Retail Shs (BIOPX) is one share class of a fund that manages $2.14B across all of its share classes (BIOIX reports the same total). Our data does not carry the assets of this share class alone. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is BIOPX actively managed or an index fund? BIOPX is actively managed: the manager selects holdings rather than tracking an index. Active funds typically charge higher expense ratios than index funds (BIOPX's is 1.31%) in exchange for the discretion to over- or under-weight positions. ### When was BIOPX launched? Baron Opportunity Fund Retail Shs (BIOPX) launched in February 2000 and is managed by Baron. ### How has BIOPX performed? BIOPX's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does BIOPX pay a dividend? Baron Opportunity Fund Retail Shs (BIOPX) currently distributes little or no income. Trailing-twelve-month yield is 3.75%. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does BIOPX pay dividends? Baron Opportunity Fund Retail Shs pays dividends Annual. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is BIOPX's dividend yield? BIOPX's trailing-twelve-month yield is 3.75%, calculated from the sum of dividends over the past year divided by the current price. ### When is BIOPX's next ex-dividend date? The most recently announced ex-dividend date for BIOPX was 2025-12-16. The next ex-date typically follows Annual; once announced it appears at the top of the dividend history table on this page. ### How much will BIOPX's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 1.31% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does BIOPX charge its expense ratio? The expense ratio is deducted in tiny daily slices from BIOPX's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does BIOPX cost more than a fund like VOO? BIOPX is actively managed (current expense ratio 1.31%). Active funds charge more than passive index trackers in exchange for the manager's discretion to over- or under-weight positions. The Cost Verdict card above tells you whether BIOPX's fee is competitive for the active-management cohort. ### Are there cheaper alternatives to BIOPX? The Lower-Fee Alternatives card above lists mutual funds following the same investment strategy as BIOPX (1.31%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/biopx - Distribution history: https://www.dividenddata.com/funds/biopx/dividend - Holdings & diversification: https://www.dividenddata.com/funds/biopx/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/biopx/expenses - Peer comparison: https://www.dividenddata.com/funds/biopx/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.